Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Sophie Verbeke

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Surgical Pathology Clinics|December 8, 2016
Dissection of Pancreatic Resection SpecimensCaroline Sophie Verbeke, Ivar Prydz Gladhaug
Current Oncology (Toronto, Ont.)|September 22, 2022
Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal AdenocarcinomaMaia Blomhoff Holm, Caroline Sophie Verbeke
Histopathology|December 20, 2011
Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessmentCaroline Sophie Verbeke, Johannes Knapp, Ivar Prydz Gladhaug
Cancers|May 28, 2022
Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination ApproachMy Linh Tran, Maia Blomhoff Holm, Caroline Sophie Verbeke
Histopathology|April 4, 2024
Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteriaMaia Blomhoff Holm, Daniela Lenggenhager, Sönke Detlefsen, et al.
Neoplasia (New York, N.Y.)|July 21, 2016
Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer CellsVegard Tjomsland, Eva Pomianowska, Monica Aasrum, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2026
Expression of glycolytic markers in cancer and stromal cells of treatment-naïve and neoadjuvantly treated pancreatic ductal adenocarcinomaMaia Blomhoff Holm, Linda Trobe Dorg, Mona-Elisabeth Rootwelt-Revheim, et al.
Current Oncology Reports|March 18, 2016
Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving LandscapeSven-Petter Haugvik, Daniel Kaemmerer, Sebastien Gaujoux, et al.
Scientific Reports|June 5, 2020
Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinomaMehran Ghaderi, Carlos Fernández Moro, Soledad Pouso Elduayen, et al.
Journal of Clinical Medicine|February 21, 2019
Kidney Involvement in Patients with Type 1 Autoimmune PancreatitisMiroslav Vujasinovic, Raffaella Maria Pozzi Mucelli, Roberto Valente, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Surgical Pathology Clinics|December 8, 2016
Dissection of Pancreatic Resection SpecimensCaroline Sophie Verbeke, Ivar Prydz Gladhaug
Current Oncology (Toronto, Ont.)|September 22, 2022
Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal AdenocarcinomaMaia Blomhoff Holm, Caroline Sophie Verbeke
Histopathology|December 20, 2011
Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessmentCaroline Sophie Verbeke, Johannes Knapp, Ivar Prydz Gladhaug
Cancers|May 28, 2022
Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination ApproachMy Linh Tran, Maia Blomhoff Holm, Caroline Sophie Verbeke
Histopathology|April 4, 2024
Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteriaMaia Blomhoff Holm, Daniela Lenggenhager, Sönke Detlefsen, et al.
Neoplasia (New York, N.Y.)|July 21, 2016
Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer CellsVegard Tjomsland, Eva Pomianowska, Monica Aasrum, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2026
Expression of glycolytic markers in cancer and stromal cells of treatment-naïve and neoadjuvantly treated pancreatic ductal adenocarcinomaMaia Blomhoff Holm, Linda Trobe Dorg, Mona-Elisabeth Rootwelt-Revheim, et al.
Current Oncology Reports|March 18, 2016
Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving LandscapeSven-Petter Haugvik, Daniel Kaemmerer, Sebastien Gaujoux, et al.
Scientific Reports|June 5, 2020
Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinomaMehran Ghaderi, Carlos Fernández Moro, Soledad Pouso Elduayen, et al.
Journal of Clinical Medicine|February 21, 2019
Kidney Involvement in Patients with Type 1 Autoimmune PancreatitisMiroslav Vujasinovic, Raffaella Maria Pozzi Mucelli, Roberto Valente, et al.
Pageof 2